Alx Oncology Holdings (ALXO) Price to FCF (2020 - 2026)
Powered by 
Analysis
Alx Oncology Holdings (ALXO) Price to FCF (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.72 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.56 Bn | 58.37 Bn | 1.37 Bn |
| 4 | Moderna | 58.22 Bn | 53.09 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.18 Bn | 44.18 Bn | - |
| 6 | BeOne Medicines | 40.08 Bn | 34.98 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.31 Bn | 32.00 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn |
| 10 | Alx Oncology Holdings | 273.31 Mn | 273.31 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -17.80 |
| Mar 31, 2026 | -11.24 |
| Dec 31, 2025 | -3.23 |
| Sep 30, 2025 | -5.72 |
| Jun 30, 2025 | -0.94 |
| Mar 31, 2025 | -1.34 |
| Dec 31, 2024 | -2.76 |
| Sep 30, 2024 | -3.76 |
| Jun 30, 2024 | -11.87 |
| Mar 31, 2024 | -14.72 |
| Dec 31, 2023 | -18.68 |
| Sep 30, 2023 | -6.62 |
| Jun 30, 2023 | -9.20 |
| Mar 31, 2023 | -6.48 |
| Dec 31, 2022 | -21.87 |
| Sep 30, 2022 | -12.55 |
| Jun 30, 2022 | -19.10 |
| Mar 31, 2022 | -32.31 |
| Dec 31, 2021 | -49.14 |
| Sep 30, 2021 | -118.41 |